Erratum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy (Oncotarget (2019) 10 (551–557) DOI: 10.18632/oncotarget.26560)

Stephanie A. Toll, Hung N. Tran, Jennifer Cotter, Alexander R. Judkins, Benita Tamrazi, Jaclyn A. Biegel, Girish Dhall, Nathan J. Robison, Kaaren Waters, Palak Patel, Robert Cooper, Ashley S. Margol

Research output: Contribution to journalComment/debate

Abstract

This article has an addendum: Signed HIPPA forms from the parents of the 2 patients who were alive at the time of manuscript submission were obtained.

Original languageEnglish
Pages (from-to)502
Number of pages1
JournalOncotarget
Volume14
Issue number1
DOIs
StatePublished - 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Erratum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy (Oncotarget (2019) 10 (551–557) DOI: 10.18632/oncotarget.26560)'. Together they form a unique fingerprint.

Cite this